Moormeier JA - Search Results

1

5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.

Vokes EE, Moormeier JA, Ratain MJ, Egorin MJ, Haraf DJ, Mick R, Weichselbaum RR. Vokes EE, et al. Among authors: moormeier ja. Cancer Chemother Pharmacol. 1992;29(3):178-84. doi: 10.1007/BF00686249. Cancer Chemother Pharmacol. 1992. PMID: 1733549 Clinical Trial.

2

What is the choice of treatment for hairy cell leukemia?

Golomb HM, Ratain MJ, Moormeier J. Golomb HM, et al. J Clin Oncol. 1989 Feb;7(2):156-8. doi: 10.1200/JCO.1989.7.2.156. J Clin Oncol. 1989. PMID: 2783730 No abstract available.

3

Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.

Moormeier JA, Ratain MJ, Westbrook CA, Vardiman JW, Daly KM, Golomb HM. Moormeier JA, et al. J Natl Cancer Inst. 1989 Aug 2;81(15):1172-4. doi: 10.1093/jnci/81.15.1172. J Natl Cancer Inst. 1989. PMID: 2746669

4

Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience.

Vogelzang NJ, Moormeier JA, Awan AM, Weichselbaum RR, Farah R, Straus FH 2nd, Schoenberg HW, Chodak GW. Vogelzang NJ, et al. Among authors: moormeier ja. J Urol. 1993 Apr;149(4):753-7. doi: 10.1016/s0022-5347(17)36199-2. J Urol. 1993. PMID: 8455237 Clinical Trial.

5

Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).

Farah R, Chodak GW, Vogelzang NJ, Awan AM, Quiet CA, Moormeier J, Schoenberg H, Weichselbaum RR. Farah R, et al. Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):413-7. doi: 10.1016/0360-3016(91)90050-e. Int J Radiat Oncol Biol Phys. 1991. PMID: 1995525 Clinical Trial.

6

High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas.

Bitran JD, Williams SF, Moormeier J, Mick R. Bitran JD, et al. Semin Oncol. 1990 Feb;17(1 Suppl 3):39-42. Semin Oncol. 1990. PMID: 1968290 No abstract available.

7

Interferon Alfa-2b Antibodies and Clinical Resistance in a Patient with Hairy Cell Leukemia.

Moormeier JA, Westbrook CA, Ratain MJ, Golomb HM. Moormeier JA, et al. Leuk Lymphoma. 1989;1(1):43-5. doi: 10.3109/10428198909042457. Leuk Lymphoma. 1989. PMID: 27456406

8

Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's Disease.

Moormeier JA, Williams SF, Kaminer LS, Ellis ED, Garner M, Farah R, Weichselbaum RR, Bitran JD. Moormeier JA, et al. Leuk Lymphoma. 1991;5(4):243-8. doi: 10.3109/10428199109068133. Leuk Lymphoma. 1991. PMID: 27467846

9

A phase I-II study of high-dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies.

Ellis ED, Williams SF, Moormeier JA, Kaminer LS, Bitran JD. Ellis ED, et al. Among authors: moormeier ja. Bone Marrow Transplant. 1990 Dec;6(6):439-42. Bone Marrow Transplant. 1990. PMID: 1982927 Clinical Trial.

10

High-dose tri-alkylator chemotherapy with autologous stem cell rescue in patients with refractory malignancies.

Moormeier JA, Williams SF, Kaminer LS, Garner M, Bitran JD. Moormeier JA, et al. J Natl Cancer Inst. 1990 Jan 3;82(1):29-34. doi: 10.1093/jnci/82.1.29. J Natl Cancer Inst. 1990. PMID: 1967148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters